Clinical trial of Phase III on the evaluation of Acetyl-L-carnitine

Sept. 2005 – Dec 2008

Clinical trial of Phase III on the evaluation of Acetyl-L-carnitine (ST 200) to reduce intensity of taxane-or platinum induced sensory neuropathy.

Co-principal investigator: Lévi F
Multicenter (N = 24), international, randomized, 172 patients

Pas de commentaire.

Ajouter un commentaire